REFERENCES
- Haney AF. Clinical decision making regarding leiomyomata: what we need in the next millen-nium. Environ Health Perspect 2000;108(Suppl 5): 835–9
- Stewart EA. Uterine fibroids. Lancet 2001;357: 293–9
- Robboy SJ, Bentley RC, Butnor K, et al. Patho-logy and pathophysiology of uterine smooth-muscle tumors. Environ Health Perspect 2000;108 (Suppl 5):779–84
- Filicori M, Hall DA, Loughlin JS, et al. A conserva-tive approach to the management of uterine leio-myoma: pituitary desensitization by a luteinizing hormone-releasing hormone analogue. Fertil Steril 1983;147:726–7
- Maheux R, Guilloteau CH, Lemay A, et al. Luteinizing hormone-releasing hormone agonist and uterine leiyo myo ma: a pilot study. Am J Obstet Gynecol 1985;152:1034–7
- Shaw RW. New approaches to the management of fibroids. Curr Opin Obstet Gynaecol1991;3:859–64
- Scialli AR, Levi AJ. Intermittent leuprolide acetate for the nonsurgical management of women with leiomyomata uteri. Fertil Steril 2000;74:540–6
- Crosignani PG, Vercellini P, Meschia M, et al. GnRH agonists before surgery for uterine leio-myomas. A review. J Reprod Med 1996;41:415–21
- Kuhlmann M, Gartner A, Schindler EM, et al. Uterine leiomyomata and sterility: therapy with gonadotropin-releasing hormone agonists and leio myo mecto my. Gynecol Endocrinol 1997;11: 169–74
- Friedman AJ, Daly M, Juneau-Norcross M, et al. Long-term medical therapy for leiomyomata uteri: a prospective, randomized study of leuprolide acetate depot plus either oestrogen—progestin or progestin 'add-back' for 2 years. Hum Reprod 1994; 9:1618–25
- Schweppe KW. Proges tins and uterine leiomyoma. Gynecol Endocrinol 1999;13(Suppl 4):21–4
- Maruo T, Matsuo H, Samoto T, et al. Effects of progesterone on uterine leiomyoma growth and apoptosis. Steroids 2000;65:585–92
- Murphy AA, Kettel LM, Morales AJ, et al. Regres-sion of uterine leiomyomata in response to the antiprogesterone RU 486.J Clin Endocrinol Metab 1993;76:513–17
- Palomba S, Affinito P, Tommaseli GA, et al. A clinical trial of the effects of tibolone administered with gonadotropin-releasing hormone analogues for the treatment of uterine leiomyomata. Fertil Steril 1998;70:111–18
- Vu K, Greenspan DL, Wu TC, et al. Cellular proliferation, estrogen receptor, progesterone receptor, and b c1-2 expression in GnRH agonist-treated uterine leiomyomas. Hum Pathol 1998;29:359–63
- Nisolle M, Gillerot S, Casanas-Roux F, et al. Immunohistochemical study of the proliferation index, oestrogen receptors and progesterone receptors A and B in leiomyomata and normal myometrium during the menstrual cycle and under gonadotrophin-releasing hormone agonist therapy. Hum Reprod 1999;14:2844–50
- Vollenhoven BJ, Pearce P, Herington AC, et al. Steroid receptor binding and messenger RNA expression in fibroids from untreated and gonadotrophin-releasing hormone agonist pre-treated women. Clin Endocrinol (04) 1994;40: 537–44
- Fernandez-Montoli ME, Diez-Gibert O, Samaniego JM, et al. Total and unbound cytosolic estrogen and progesterone receptors in myo-metrium and fibroid after gonadotropin-releasing hormone ago nist treatment. Fertil Steril 1995;63: 522–7
- EORTC Breast Cancer Cooperative Group. Revision of the standards for the assessment of hormone receptors in human breast cancer. Eur J Cancer 1980;16:1513–15
- Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein—dye binding. Anal Biochem 1976;72:248–54
- Kuiper GG, Enmark E, Pelto-Huikko M, et al. Cloning of a novel receptor expressed in rat pros-tate and ovary. Proc Natl Acad Sci USA 1996;93: 5925–30
- Viville B, Charnock-Jones DS, Sharkey AM, et al. Distribution of the A and B forms of the progester-one receptor messenger ribonucleic acid and protein in uterine leiomyomata and adjacent myometrium. Hum Reprod 1997;12:815–22
- Jeng M-H, Shupnik MA, Bender TP, et al. Estro-gen receptor expression and function in long-term estrogen-deprived human breast cancer cells. Endocrinology 1998;139:4164–74
- Vermeulen-Meiners C, Benedek-Jaszmann 14, Haspels AA, et al. The endogenous concentration of estradiol and estrone in normal human post-menopausal endometrium.J Steroid Biochem 1984; 21:607–12
- Wiegerinck MAHM, Poortman J, Donker GH, et al. In vivo uptake and subcellular distribution of tritium labelled estrogens in human endometrium, myometrium and vagina. J Clin Endocrinol Metab 1983;56:76–86